Filing Details

Accession Number:
0001140361-13-004523
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-05 09:13:01
Reporting Period:
2013-01-31
Filing Date:
2013-02-05
Accepted Time:
2013-02-05 09:13:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1023869 Merilee Raines One Idexx Drive
Westbrook ME 04092
Executive Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-01-31 47,576 $95.27 45,500 No 4 S Direct
Common Stock Disposition 2013-01-31 7,500 $95.96 38,000 No 4 S Direct
Common Stock Disposition 2013-01-31 27,216 $95.46 39,159 No 4 S Indirect by Charitable Remainder Trust
Common Stock Disposition 2013-01-31 4,159 $95.98 35,000 No 4 S Indirect by Charitable Remainder Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect by Charitable Remainder Trust
No 4 S Indirect by Charitable Remainder Trust
Footnotes
  1. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.81 to $95.80, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, 4 and 5 to this Form 4.
  2. Excludes 10,870 and 42,075 shares previously owned directly, which were contributed to a Charitable Remainder Trust on 12/4/2012 and 1/23/2013, respectively.
  3. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.81 to $96.09, inclusive.
  4. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.83 to $95.8201, inclusive.
  5. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.83 to $96.09, inclusive.